Connect with us

Breaking News

Trump administration tiptoes into testing prior authorization in traditional Medicare

Published

on


Traditional Medicare plan holders have typically not had to wait for prior authorization before receiving medical treatment.

Until now.

The Centers for Medicare & Medicaid Services (CMS) recently announced a new program to test prior authorization requirements for certain services in six states starting Jan. 1.

The states — New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington — will apply prior authorization evaluations to more than a dozen services.

CMS says the pilot program is intended to root out “fraud, waste, and abuse,” but as Medicare Advantage members know well, prior authorization can lead to frustrating delays in care.

CMS will contract with private companies to deploy “enhanced technologies, including artificial intelligence (AI)” to conduct the authorization reviews.

It won’t apply to in-patient or emergency services or treatments “that would pose a substantial risk to patients if significantly delayed,” according to a CMS press release. Specific services that will require prior authorization are skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy.

There is genuine concern about the costs of some of these items and services. A recent New York Times article highlighted pricey medical products, including paper-thin bandages made of dried bits of placenta, for Medicare patients.

The Biden administration had approved a plan to limit Medicare’s coverage of the bandages, known as skin substitutes, which were reportedly being sold for roughly $10,000 per square inch. An updated Medicare policy proposes setting a significantly lower payment rate.

The new prior authorization program “is focused on reducing wasteful spending, which is an important goal for Medicare,” Jeffrey Marr, a health economist at the Brown University School of Public Health, told Yahoo Finance.

“I expect that the use of prior authorization in this model is likely to reduce the overall level of Medicare spending,” he said. “Selecting potentially low-value services is a critical part of setting up a well-functioning prior authorization system.”

The key question for CMS to address is whether prior authorization can work in traditional Medicare in a way that does not deny or discourage high-value care that improves beneficiaries’ health, Marr said.

One red flag: “The companies that will make the prior authorization decisions will be paid a percentage of the savings that they generate for Medicare. This creates an incentive for participants to deny a high share of services,” he said.

How often do prior authorizations pop up for seniors with Medicare and Medicare Advantage plans?

Story Continues



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *